We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
844 result(s) found, displaying 91 to 100
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: beclometasone dipropionate, formoterol fumarate dihydrate.
-
Prescription medicine registrationActive ingredients: sugammadex sodium.
-
Mar-2025Prescription medicine evaluationActive ingredient: teduglutide.
-
Prescription medicine registrationActive ingredients: Liraglutide.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2025
-
Prescription medicine registrationActive ingredients: Ustekinumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA TERIPARATIDE teriparatide 250 microgram/mL solution for injection cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA FOSFOMYCIN fosfomycin (as trometamol) 3 g granules for oral solution sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPFOSIN fosfomycin (as trometamol) 3 g granules for oral solution sachet.